Commons Sense

House of Commons · Written Ministerial Statement

Respiratory Syncytial Virus Immunisation Programmes

18 July 2024 · Department of Health and Social Care

Proposed by Andrew Gwynne Ind Gorton and Denton

NHS

Summarised by AI from the official record, so it can contain mistakes.

View on Parliament.uk

At a glance

Key points

  • The Respiratory Syncytial Virus (RSV) immunisation programme for infants and older adults begins in September 2024.
  • Pregnant women will be offered RSV vaccinations from 28 weeks of pregnancy onwards.
  • A one-off RSV vaccination campaign will target individuals aged 75 to 79 from September 2024 to August 2025.

Issue summary

The statement confirms the start of a new immunisation programme against Respiratory Syncytial Virus (RSV) for infants and older adults.

Action requested

The minister is announcing that the RSV vaccination programme will begin in September, with pregnant women offered vaccinations from 28 weeks onwards and all those turning 75 receiving routine vaccinations. A one-off campaign for individuals aged 75-79 will run from September 2024 to August 2025.

Key facts

  • RSV causes over 30,000 hospital admissions for children under 5 and around 9,000 admissions amongst adults over the age of 75 each year.
  • The Joint Committee on Vaccination and Immunisation (JCVI) advised in June 2023 that a cost-effective RSV immunisation programme should be developed.
  • The vaccination programme for pregnant women will begin from September 2023, offering vaccinations from 28 weeks of pregnancy until full term.
  • A one-off campaign for older adults aged 75-79 will run from September 2024 to August 2025.
▸ Assessment & feedback
Summary accuracy